SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-013032
Filing Date
2024-05-13
Accepted
2024-05-13 17:00:43
Documents
2
Period of Report
2024-05-07

Document Format Files

Seq Description Document Type Size
1 form3-05132024_090523.html 3  
1 form3-05132024_090523.xml 3 1781
2 ex24-05132024_090524.htm EX-24 4588
  Complete submission text file 0001415889-24-013032.txt   7912
Mailing Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122
Business Address 4350 LA JOLLA VILLAGE DRIVE SUITE 800 San Diego CA 92122 858-550-0780
Tracon Pharmaceuticals, Inc. (Issuer) CIK: 0001394319 (see all company filings)

IRS No.: 342037594 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 5305 VIDA RESIDENCE MARSA DUBAI C0 00000
Business Address
Lazar David E. (Reporting) CIK: 0001932843 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36818 | Film No.: 24940059